Drug Shortage Report for SANDOZ LISINOPRIL HCT

Last updated on 2021-05-03 History
Report ID 127772
Drug Identification Number 02302373
Brand name SANDOZ LISINOPRIL HCT
Common or Proper name SANDOZ LISINOPRIL HCT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) LISINOPRIL HYDROCHLOROTHIAZIDE
Strength(s) 20MG 12.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30 TAB UD CA
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-10-30
Estimated end date 2021-05-07
Actual end date
Shortage status Actual shortage
Updated date 2021-05-03
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-05-03 French Compare
v7 2021-05-03 English Compare
v6 2021-04-27 French Compare
v5 2021-04-27 English Compare
v4 2020-11-27 French Compare
v3 2020-11-27 English Compare
v2 2020-11-04 French Compare
v1 2020-11-04 English Compare